The use of frailty scores to predict tolerance to chemotherapy in patients with metastatic prostate cancer
Affiliation
Lancashire Teaching Hospitals NHS Foundation TrustIssue Date
2023
Metadata
Show full item recordCitation
Portner R, Ticknell G, Song YP, Hudson A, Choudhury A. The Use of Frailty Scores to Predict Tolerance to Chemotherapy in Patients with Metastatic Prostate Cancer. Clinical Oncology. 2023 Feb;35(2):E241-E. PubMed PMID: WOS:001038297600021.Journal
Clinical OncologyDOI
10.1016/j.clon.2022.11.040Additional Links
https://doi.org/10.1016/j.clon.2022.11.040Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2022.11.040